Ref20c15
A pilot study on the liver protective effect
of silybinphosphatidylcholine complex
(Siliphos®) in chronic active hepatitis
G. Buzzelli, S1., Moscarella, A. 1, Giusti, A. 1, Duchini, C. 1, Marena and M.
Lampertico 2,1
1.Instituto di Clinica Medica , Universita Degli Studi di Firenze, Firenze and
2. Medical Department, Inverni Dell Beffa, Milan Italy
Int. J. Clin. Pharmacol. Ther. Toxicol. 31, 456
(1993)
See
National Library of Medicine Citation
This was a 20 patient study. 10 patients were treated and 10
were given a placebo. Liver enzyme levels were reduced by 20-30%
on average with just one week of usage.In
conclusion, IdB 1016 (Siliphos®) seems to improve the biochemical signs of
hepatocellular necrosis and/or increases cellular permeability in patients affected
by chronic active hepatitis.
This chart shows the dramatic decrease in elevated
liver enzymes in patients with chronic active hepatitis after just
7 days of using the active ingredient in Maximum Milk Thistle
daily.
|